Jesse Ledger
Corporate Officer/Principal at Canadian Healthcare Licensing Association
Profile
Jesse F.
Ledger is currently the President & Chief Executive Officer at Nuvo Pharmaceuticals, Inc. He is also a Member at the Canadian Healthcare Licensing Association.
Previously, he worked as the Director-Business Development at SteriMax, Inc. and as the VP-Business Development & International Business at Aralez Pharmaceuticals Canada, Inc. Mr. Ledger completed his undergraduate degree at Trent University.
Jesse Ledger active positions
| Companies | Position | Start |
|---|---|---|
| Canadian Healthcare Licensing Association | Corporate Officer/Principal | - |
Former positions of Jesse Ledger
| Companies | Position | End |
|---|---|---|
| TRIBUTE PHARMACEUTICALS CANADA INC | Corporate Officer/Principal | - |
SteriMax, Inc.
 SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Corporate Officer/Principal | - |
| NUVO PHARMACEUTICALS INC. | Chief Executive Officer | - |
Training of Jesse Ledger
| Trent University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Aralez Pharmaceuticals Canada, Inc.
 Aralez Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Health Technology |
| Canadian Healthcare Licensing Association |
- Stock Market
- Insiders
- Jesse Ledger
